Castleman Disease – how machine learning can support treatment
February 20, 2019
Combining large omic and clinical trial data sets with machine learning algorithms has allowed Medidata and CDCN to identify six new patient subgroups of rare Castleman disease. How can this discovery advance diagnostics and drug development for this rare disease? Allie Nawrat finds out.
After hearing a talk by Castleman Disease Collaborative Network co-founder Dr David Fajgenbaum as part of a lecture series about challenging topics in the life sciences, artificial intelligence firm Medidata decided to stay in touch with Fajgenbaum and his company.Medidata chief data officer David Lee explains: “One day we were talking [with Dr Fajgenbaum] about how far the [Rave Omics] product and machine learning has come, and he was telling us about how much data he has been able to collect on [Castleman disease].“Then as a proof of concept, we decided to work on this collaboration together.”Combining CDCN’s large data sets from patients suffering with this rare, inflammatory disease with Rave Omics’ machine learning capabilities has led to novel insights about the disease that help to understand which patients will respond best to existing treatments and identify new drug targets for patients responding less well. Continue reading
We may collect information using “cookies.” Cookies are small data files stored on the hard drive of your computer or mobile device by a website. We may use both session cookies (which expire once you close your web browser) and persistent cookies (which stay on your computer or mobile device until you delete them) to provide you with a more personal and interactive experience on our Site.
Necessary cookies are essential and are used to provide you with services available through Medidata website. For instance, these cookies allow Medidata to remember your choices about cookies preferences, to record your interface customization trackers e.g. for the choice of language used by the website. Necessary cookies are enabled by default and cannot be switched off. To see the list of the cookies used for this purpose, click here .
Functional cookies are used to provide you with contents and proposals that correspond to your interactions. They may consist of information logged on your device or recorded as you navigate through Medidata website. These cookies also allow us to analyze site usage so we can measure and improve performance. To see the list of the cookies used for these purposes, click here.
Advertising cookies are used to enable Medidata and its trusted Medidata business stakeholders to serve ads that are relevant to your interests. The intention is to display ads that are relevant to you.
Oracle / Eloqua
To see the list of the cookies used for this purpose, click here.